Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $16.56 billion. The enterprise value is $14.18 billion.
| Market Cap | 16.56B |
| Enterprise Value | 14.18B |
Important Dates
The next estimated earnings date is Tuesday, October 28, 2025, before market open.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 195.28 million shares outstanding. The number of shares has decreased by -11.03% in one year.
| Current Share Class | 195.28M |
| Shares Outstanding | 195.28M |
| Shares Change (YoY) | -11.03% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 86.93% |
| Float | 163.04M |
Valuation Ratios
The trailing PE ratio is 19.41 and the forward PE ratio is 12.92. Incyte's PEG ratio is 0.07.
| PE Ratio | 19.41 |
| Forward PE | 12.92 |
| PS Ratio | 3.58 |
| Forward PS | 3.20 |
| PB Ratio | 3.95 |
| P/TBV Ratio | 4.26 |
| P/FCF Ratio | 17.28 |
| P/OCF Ratio | 16.51 |
| PEG Ratio | 0.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.37, with an EV/FCF ratio of 14.80.
| EV / Earnings | 16.28 |
| EV / Sales | 3.09 |
| EV / EBITDA | 13.37 |
| EV / EBIT | 14.67 |
| EV / FCF | 14.80 |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.85 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 394.96 |
Financial Efficiency
Return on equity (ROE) is 24.30% and return on invested capital (ROIC) is 16.67%.
| Return on Equity (ROE) | 24.30% |
| Return on Assets (ROA) | 11.52% |
| Return on Invested Capital (ROIC) | 16.67% |
| Return on Capital Employed (ROCE) | 21.28% |
| Revenue Per Employee | $1.75M |
| Profits Per Employee | $332,774 |
| Employee Count | 2,617 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 23.30 |
Taxes
In the past 12 months, Incyte has paid $391.58 million in taxes.
| Income Tax | 391.58M |
| Effective Tax Rate | 31.02% |
Stock Price Statistics
The stock price has increased by +27.69% in the last 52 weeks. The beta is 0.75, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +27.69% |
| 50-Day Moving Average | 79.19 |
| 200-Day Moving Average | 70.24 |
| Relative Strength Index (RSI) | 55.42 |
| Average Volume (20 Days) | 1,660,418 |
Short Selling Information
The latest short interest is 7.51 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 7.51M |
| Short Previous Month | 9.60M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 4.61% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
In the last 12 months, Incyte had revenue of $4.58 billion and earned $870.87 million in profits. Earnings per share was $4.37.
| Revenue | 4.58B |
| Gross Profit | 2.44B |
| Operating Income | 966.47M |
| Pretax Income | 351.14M |
| Net Income | 870.87M |
| EBITDA | 1.06B |
| EBIT | 966.47M |
| Earnings Per Share (EPS) | $4.37 |
Balance Sheet
The company has $2.42 billion in cash and $42.41 million in debt, giving a net cash position of $2.38 billion or $12.18 per share.
| Cash & Cash Equivalents | 2.42B |
| Total Debt | 42.41M |
| Net Cash | 2.38B |
| Net Cash Per Share | $12.18 |
| Equity (Book Value) | 4.17B |
| Book Value Per Share | 21.49 |
| Working Capital | 2.37B |
Cash Flow
In the last 12 months, operating cash flow was $1.00 billion and capital expenditures -$44.81 million, giving a free cash flow of $958.08 million.
| Operating Cash Flow | 1.00B |
| Capital Expenditures | -44.81M |
| Free Cash Flow | 958.08M |
| FCF Per Share | $4.91 |
Margins
Gross margin is 53.22%, with operating and profit margins of 21.08% and 18.99%.
| Gross Margin | 53.22% |
| Operating Margin | 21.08% |
| Pretax Margin | 27.53% |
| Profit Margin | 18.99% |
| EBITDA Margin | 23.14% |
| EBIT Margin | 21.08% |
| FCF Margin | 20.90% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.03% |
| Shareholder Yield | 11.03% |
| Earnings Yield | 5.26% |
| FCF Yield | 5.79% |
Analyst Forecast
The average price target for Incyte is $80.31, which is -5.29% lower than the current price. The consensus rating is "Buy".
| Price Target | $80.31 |
| Price Target Difference | -5.29% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | -0.25% |
| EPS Growth Forecast (5Y) | 90.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 6.46 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.46 |
| Piotroski F-Score | 7 |